U.S. Construction Stock News

On October 31, 2025, Bit Digital filed an omnibus shelf registration enabling flexible future issuance of securities, including ordinary shares, preference shares, debt securities, warrants, units, and subscription rights. This filing provides Bit Digital with increased agility in capital raising, signaling to the market that the company may consider upcoming financial moves or adjustments to its capital structure. We'll explore how this expanded capital-raising flexibility could influence...

DRDGOLD (NYSE:DRD) has caught investor attention as it pursues a goal of producing 200,000 ounces of gold annually from tailings by 2029. The company maintains an impressive 18-year dividend streak and follows a debt-free expansion strategy. See our latest analysis for DRDGOLD. DRDGOLD’s share price momentum has been remarkable this year, climbing almost 190% year-to-date and surging 71% over the past 90 days. The company’s operational goals and commitment to consistent dividends are taking...

FormFactor (FORM) just released its third quarter results, showing both revenue and net income down from last year. The company also updated its guidance for the coming quarter, which puts investors’ focus squarely on its outlook. See our latest analysis for FormFactor. FormFactor’s updated guidance and softer quarterly results have certainly influenced investor sentiment, but momentum in the share price is building rapidly. Even with a challenging start to the year, the stock has delivered a...

Somnigroup International Inc. reported third-quarter 2025 results that exceeded analyst expectations with revenue of US$2.12 billion and net income of US$177.4 million, while also declaring a fourth-quarter dividend of US$0.15 per share payable in December. The company raised its full-year adjusted earnings guidance and reached an all-time high stock price, driven by increased sales, positive operating cash flow, and continued momentum in international and direct channels despite some...

Akero Therapeutics (AKRO) stock has been quietly trending higher this month, gaining roughly 16% despite little in the way of major news. Many investors are revisiting the company’s progress and recent momentum. See our latest analysis for Akero Therapeutics. Akero’s impressive 16% share price return this month builds on a strong year, with momentum clearly gaining steam. The stock has surged 92.5% year-to-date. While recent news has been quiet, long-term total shareholder returns have also...

Peoples Bancorp (PEBO) saw both its CEO and a director purchase shares this month. This move is often interpreted as management signaling confidence in the company’s future direction. The purchases came after solid third-quarter earnings and fresh analyst coverage. See our latest analysis for Peoples Bancorp. Peoples Bancorp’s share price has seesawed over 2025, recently closing at $28.95. Despite robust earnings and signs of management confidence, the year-to-date share price return stands...

If you have ever found yourself wondering whether Science Applications International stock is truly undervalued or just misunderstood by the market, you are not alone. The stock has been on quite a rollercoaster lately, with a 2.0% dip in the past week, 9.4% over the last month, and a striking 38.8% over the past year. The recent price moves have caught the eye of investors, with broader uncertainty about the defense and government services sector making headlines. Discussions around federal...

In recent news, Voyager Technologies raised its full-year 2025 sales guidance to the upper end of its US$165 million to US$170 million range, citing strong performance from recent acquisitions and substantial defense segment growth. This announcement underscores the company's focus on execution and expansion, exemplified by continued momentum in its government and commercial partnerships despite sector volatility. We will explore how Voyager Technologies' upgraded sales outlook and robust...

Vail Resorts (MTN) shares have caught some attention lately, especially as the company navigates a period of subdued performance, dipping about 5% over the past month. Investors are watching closely to see how broader trends will shape the next quarter. See our latest analysis for Vail Resorts. After a challenging start to the year, Vail Resorts’ 1-year total shareholder return of -12.5% and a 30-day share price return of -4.6% highlight momentum that is still fading. At the same time, a...

Toast (NYSE:TOST) just posted its third-quarter financial results, reporting a jump in both revenue and profitability. The company also rolled out a new AI assistant and unveiled a strategic global partnership with Uber. These moves have definitely caught investor attention. See our latest analysis for Toast. Despite a choppy ride over the past few months, including a sharp pullback in the last quarter, Toast’s latest financial results and big-name partnerships appear to be restoring investor...

Gibraltar Industries reported third-quarter and nine-month 2025 results on October 30, showing higher sales year-over-year but shifting from net income to a US$89.06 million net loss for the quarter and a US$41.94 million net loss for the year to date. Despite increased revenues, the swing to losses and more cautious full-year earnings guidance highlighted underlying profitability challenges and raised questions about the sustainability of recent operational improvements. We'll now explore...

KeyCorp (KEY) has caught attention with its Q3 2025 numbers, swinging from last year’s loss to a $489 million profit. While many regional banks struggle, this turnaround highlights KeyCorp’s approach to growth in the face of industry headwinds. See our latest analysis for KeyCorp. KeyCorp’s share price has edged higher in 2025, reflecting cautious optimism as investors digest its turnaround and recent strong quarterly results. This comes even as regional banks broadly face industry pressures...

On October 27, 2025, LeMaitre Vascular's Board of Directors approved a quarterly dividend of US$0.20 per share, and the company reported strong third-quarter results with year-over-year growth in revenue, net income, and earnings per share. Alongside this, LeMaitre issued positive guidance for both the fourth quarter and full year, reflecting confidence in ongoing demand and operational momentum. With management projecting continued sales and earnings growth, we'll examine how this guidance...

Xeris Biopharma Holdings recently reported record third quarter results, with revenue rising to US$74.38 million and achieving net income for the first time, compared to a net loss in the previous year. An important development is the company raising its full-year 2025 revenue guidance and planning to expand its sales and patient support teams, pointing to accelerating business momentum. We’ll explore how Xeris’s milestone of achieving net profitability may alter its investment outlook and...

Roblox (RBLX) shares took a sharp turn after the company’s third-quarter earnings report. The stock climbed on record bookings and revenue, then dropped over 20% as management flagged ongoing losses and coming margin pressure. See our latest analysis for Roblox. Roblox shares have seen wild swings lately, with a 1-day share price bounce of 5.5% quickly overshadowed by a punishing 15% drop over the last month. While blockbuster growth and viral engagement have fueled long-term optimism,...

Kilroy Realty Corporation released its third quarter and nine-month 2025 earnings, reporting net income of US$156.22 million for the quarter and US$263.68 million for the nine-month period, both of which were considerably higher than the prior year despite lower year-over-year sales and revenue. This substantial increase in profitability, particularly in earnings per share, stands out given the challenging environment for office real estate and softer revenue trends. With third quarter net...

Adaptive Biotechnologies (ADPT) delivered strong third quarter earnings, more than doubling revenue compared to last year and returning to profitability. The company also raised its full-year MRD revenue guidance, signaling growing momentum. See our latest analysis for Adaptive Biotechnologies. Adaptive Biotechnologies’ comeback is showing up in the share price, too. After a choppy few months, the stock is up an impressive 138.9% year-to-date, and its 154.1% total shareholder return over the...

Wondering if Procter & Gamble is a smart buy right now? You are not alone, as plenty of investors are re-evaluating its value as market conditions shift. The stock has seen mild downward movement recently, slipping 2.3% over the past week and 11.4% year-to-date. This could hint at shifting sentiment or new growth opportunities ahead. Recent headlines have focused on the company's strategic acquisitions and expanded sustainability initiatives, which add important context to the recent price...

Hut 8 (NasdaqGS:HUT) shares were active this week, moving up 3% in the latest session. Investors are weighing recent trading patterns and underlying fundamentals as they search for signals about the company’s future direction within the rapidly evolving digital asset sector. See our latest analysis for Hut 8. Despite a sharp drop last week, Hut 8's 129% share price return over the past 90 days and 103.7% year-to-date gain stand out in the digital asset space. This reflects building momentum...

Wondering if Gambling.com Group is a golden opportunity trading below its fair value, or if the recent turbulence has put the stock in the bargain bin? Let’s take a closer look at what is really behind the current price. Shares have slipped by 6.7% over the last week and are down a hefty 54.6% year-to-date, highlighting how much sentiment and perceived risk can shift for this stock. Ongoing discussions surrounding digital gambling legislation and increased competition in the affiliate...

Jefferies Financial Group (JEF) shares moved after Bragar Eagel & Squire, P.C. announced an investigation into the company’s handling of receivables tied to the bankruptcy of First Brands. This development raises new legal and financial questions for investors. See our latest analysis for Jefferies Financial Group. This legal uncertainty has added to an already volatile year for Jefferies, following several routine bond offerings and a sharp drop in share price. The latest 1-day share price...

Synopsys (SNPS) is under the spotlight after a class action lawsuit was filed. The lawsuit accuses the company and some executives of misleading investors about challenges in its Design IP business connected to increased AI customer demand. See our latest analysis for Synopsys. It has been a volatile period for Synopsys, with the share price tumbling almost 36% in a single day after the recent lawsuit and disappointing Q3 results came to light. The moves capped off a rough stretch for the...

Texas Pacific Land Corporation recently reported third-quarter 2025 results that showed year-over-year increases in revenue to US$203.09 million and net income to US$121.24 million, alongside higher oil, natural gas, and NGL production volumes. The company also affirmed its quarterly dividend and secured an undrawn US$500 million revolving credit facility, highlighting both strengthened shareholder returns and expanded financial flexibility for future operations or investments. We'll examine...

Disc Medicine (IRON) has been in the spotlight after submitting a New Drug Application for bitopertin, earning an FDA National Priority Voucher, and unveiling early trial data in several blood disorders. These moves highlight growing pipeline momentum and increasing investor interest. See our latest analysis for Disc Medicine. Disc Medicine's momentum has translated into a remarkable 44.5% share price return over the last three months and a 19.3% gain for the past month, even with some...